Methanandamide hyperpolarizes gastric arteries by stimulation of TRPV1 receptors on perivascular CGRP containing nerves

Journal of Cardiovascular Pharmacology

Volumn 47, Issue 2, 2006, Pages 303-309

  Breyne, Joke ^a   Vanheel, Bert ^a,b  

^a GHENT UNIVERSITY   (Belgium)

^b GHENT UNIVERSITY HOSPITAL   (Belgium)

Author keywords

Blood flow; Cannabinoids; Endothelial factors; Vascular smooth muscle membrane potential; Vasoactive agents

Indexed keywords

ADENOSINE TRIPHOSPHATE SENSITIVE POTASSIUM CHANNEL; CALCITONIN GENE RELATED PEPTIDE; CANNABINOID; CAPSAZEPINE; GLIBENCLAMIDE; METHANANDAMIDE; VANILLOID RECEPTOR 1; ARACHIDONIC ACID DERIVATIVE; CAPSAICIN; DRUG DERIVATIVE; DRUG RECEPTOR; TRPV1 RECEPTOR; VANILLOID RECEPTOR;

ANIMAL TISSUE; ARTERY MUSCLE; ARTICLE; CELL MEMBRANE POTENTIAL; CONTROLLED STUDY; FEMALE; HYPERPOLARIZATION; MESENTERIC ARTERY; MICROELECTRODE; NONHUMAN; PRIORITY JOURNAL; RAT; SENSORY NERVE; STOMACH BLOOD FLOW; STOMACH PROTECTION; VASCULAR SMOOTH MUSCLE; VASODILATATION; ABDOMEN; ANIMAL; CHEMISTRY; DRUG ANTAGONISM; DRUG EFFECT; ELECTROPHYSIOLOGY; KINETICS; PERIPHERAL NERVOUS SYSTEM; PHYSIOLOGY; VASCULARIZATION; WISTAR RAT;

ABDOMEN; ANIMALS; ARACHIDONIC ACIDS; CALCITONIN GENE-RELATED PEPTIDE; CANNABINOIDS; CAPSAICIN; ELECTROPHYSIOLOGY; FEMALE; KINETICS; MEMBRANE POTENTIALS; MESENTERIC ARTERIES; MICROELECTRODES; MUSCLE, SMOOTH, VASCULAR; PERIPHERAL NERVOUS SYSTEM; RATS; RATS, WISTAR; RECEPTORS, DRUG; TRPV CATION CHANNELS;

EID: 33746436785     PISSN: 01602446     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.fjc.0000205053.53946.10     Document Type: Article

References (45)

1. Pertwee RG. Cannabinoids and the gastrointestinal tract. Gut. 2001;48:859-867.
2. Izzo AA, Mascolo N, Capasso F. The gastrointestinal pharmacology of cannabinoids. Curr Opin Pharmacol. 2001;1:597-603.
3. Krowicki ZK, Moerschbaecher JM, Winsauer PJ, et al. Delta9- tetrahydrocannabinol inhibits gastric motility in the rat through cannabinoid CB1 receptors. Eur J Pharmacol. 1999;371:187-196.
4. Lehmann A, Blackshaw LA, Branden L, et al. Cannabinoid receptor agonism inhibits transient lower esophageal sphincter relaxations and reflux in dogs. Gastroenterology. 2002;123:1129-1134.
5. Germano MP, D'Angelo V, Mondello MR, et al. Cannabinoid CB1-mediated inhibition of stress-induced gastric ulcers in rats. Naunyn Schmiedebergs Arch Pharmacol. 2001;363:241-244.
6. Coruzzi G, Adami M, Coppelli G, et al. Inhibitory effect of the cannabinoid receptor agonist WIN 55,212-2 on pentagastrin-induced gastric acid secretion in the anaesthetized rat. Naunyn Schmiedebergs Arch Pharmacol. 1999;360:715-718.
7. Kawano S, Tsuji S. Role of mucosal blood flow: a conceptional review in gastric mucosal injury and protection. J Gastroenterol Hepatol. 2000;15:D1-D6.
8. Holzer P. Neural emergency system in the stomach. Gastroenterology. 1998;114:823-839.
9. Holzer P, Pabst MA. Visceral afferent neurons: role in gastric mucosal protection. News Physiol Sci. 1999;14:201-206.
10. Tani N, Miyazawa M, Miwa T, et al. Immunohistochemical localization of calcitonin gene-related peptide in the human gastric mucosa. Digestion. 1999;60:338-343.
11. Mizuguchi S, Ohno T, Hattori Y, et al. Calcitonin gene-related peptide released by capsaicin suppresses myoelectrical activity of gastric smooth muscle. J Gastroenterol Hepatol. 2005;20:611-618.
12. Holzer P, Lippe IT. Stimulation of afferent nerve endings by intragastric capsaicin protects against ethanol-induced damage of gastric mucosa. Neuroscience. 1988;27:981-987.
13. Kinoshita Y, Inui T, Chiba T. Calcitonin gene-related peptide: a neurotransmitter involved in capsaicin-sensitive afferent nerve-mediated gastric mucosal protection. J Clin Gastroenterol. 1993;17:S27-S32.
14. Li YJ, Duckles SP. Effect of endothelium on the actions of sympathetic and sensory nerves in the perfused rat mesentery. Eur J Pharmacol. 1992;210:23-30.
15. Gray DW, Marshall I. Human alpha-calcitonin gene-related peptide stimulates adenylate-cyclase and guanylate-cyclase and relaxes rat thoracic aorta by releasing nitric-oxide. Br J Pharmacol. 1992;107:691-696.
16. Zygmunt PM, Petersson J, Andersson DA, et al. Vanilloid receptors on sensory nerves mediate the vasodilator action of anandamide. Nature. 1999;400:452-457.
17. Ralevic V. Cannabinoid modulation of peripheral autonomic and sensory neurotransmission. Eur J Pharmacol. 2003;472:1-21.
18. Ahluwalia J, Urban L, Bevan S, et al. Anandamide regulates neuropeptide release from capsaicin-sensitive primary sensory neurons by activating both the cannabinoid 1 receptor and the vanilloid receptor 1 in vitro. Eur J Neurosci. 2003;17:2611-2618.
19. Vanheel B, Van de Voorde J. Regional differences in anandamide- and methanandamide-induced membrane potential changes in rat mesenteric arteries. J Pharmacol Exp Ther. 2001;296:322-328.
20. Mulvany MJ, Halpern W. Contractile properties of small arterial resistance vessels in spontaneously hypertensive and normotensive rats. Circ Res. 1977;41:19-26.
21. Vanheel B, Van de Voorde J. Evidence against the involvement of cytochrome P450 metabolites in endothelium-dependent hyperpolarization of the rat main mesenteric artery. J Physiol. 1997;501:331-341.
22. + channels in endothelium-dependent hyperpolarization of rat small mesenteric arteries. Can J Physiol Pharmacol. 2004;82:65-71.
23. Ellis EF, Moore SF, Willoughby KA. Anandamide and delta 9-THC dilation of cerebral arterioles is blocked by indomethacin. Am J Physiol. 1995;269:H1859-H1864.
24. Randall MD, Alexander SPH, Bennett T, et al. An endogenous cannabinoid as an endothelium-derived vasorelaxant. Biochem Biophys Res Commun. 1996;229:114-120.
25. Deutsch DG, Goligorsky MS, Schmid PC, et al. Production and physiological actions of anandamide in the vasculature of the rat kidney. J Clin Invest. 1997;100:1538-1546.
26. Pratt PF, Hillard CJ, Edgemond WS, et al. N-arachidonylethanolamide relaxation of bovine coronary artery is not mediated by CB1 cannabinoid receptor. Am J Physiol. 1998;43:H375-H381.
27. Chataigneau T, Feletou M, Thollon C, et al. Cannabinoid CB1 receptor and endothelium-dependent hyperpolarization in guinea-pig carotid, rat mesenteric and porcine coronary arteries. Br J Pharmacol. 1998;123:968-974.
28. White R, Hiley CR. A comparison of EDHF-mediated and anandamide-induced relaxations in the rat isolated mesenteric artery. Br J Pharmacol. 1997;122:1573-1584.
29. Fulton D, Quilley J. Evidence against anandamide as the hyperpolarizing factor mediating the nitric oxide-independent coronary vasodilator effect of bradykinin in the rat. J Pharmacol Exp Ther. 1998;286:1146-1151.
30. Chaytor AT, Martin PE, Evans WH, et al. The endothelial component of cannabinoid-induced relaxation in rabbit mesenteric artery depends on gap junctional communication. J Physiol. 1999;520:539-550.
31. Ross RA, Gibson TM, Brockie HC, et al. Structure-activity relationship for the endogenous cannabinoid, anandamide, and certain of its analogues at vanilloid receptors in transfected cells and vas deferens. Br J Pharmacol. 2001;132:631-640.
32. Ellington HC, Cotter MA, Cameron NE, et al. The effect of cannabinoids on capsaicin-evoked calcitonin gene-related peptide (CGRP) release from the isolated paw skin of diabetic and non-diabetic rats. Neuropharmacology. 2002;42:966-975.
33. 2+ in endothelial cells. Br J Pharmacol. 1999;126:1593-1600.
34. Roberts LA, Christie MJ, Connor M. Anandamide is a partial agonist at native vanilloid receptors in acutely isolated mouse trigeminal sensory neurons. Br J Pharmacol. 2002;137:421-428.
35. Jarai Z, Wagner JA, Varga K, et al. Cannabinoid-induced mesenteric vasodilation through an endothelial site distinct from CB1 or CB2 receptors. Proc Natl Acad Sci USA. 1999;96:14136-14141.
36. O'Sullivan SE, Kendall DA, Randall MD. Heterogeneity in the mechanisms of vasorelaxation to anandamide in resistance and conduit rat mesenteric arteries. Br J Pharmacol. 2004;142:435-442.
37. Ford WR, Honan SA, White R, et al. Evidence of a novel site mediating anandamide-induced negative inotropic and coronary vasodilatator responses in rat isolated hearts. Br J Pharmacol. 2002;135:1191-1198.
38. Wagner JA, Varga K, Jarai Z, et al. Mesenteric vasodilation mediated by endothelial anandamide receptors. Hypertension. 1999;33:429-434.
39. Holzer P. Capsaicin - Cellular targets, mechanisms of action, and selectivity for thin sensory neurons. Pharmacol Rev. 1991;43:143-201.
40. + channels. Nature. 1990;344:770-773.
41. Doi K, Nagao T, Kawakubo K, et al. Calcitonin gene-related peptide affords gastric mucosal protection by activating potassium channel in wistar rat. Gastroenterology. 1998;114:71-76.
42. Brain SD, Williams TJ, Tippins JR, et al. Calcitonin gene-related peptide is a potent vasodilator. Nature. 1985;313:54-56.
43. Kawasaki H, Takasaki K, Saito A, et al. Calcitonin gene-related peptide acts as a novel vasodilator neurotransmitter in mesenteric resistance vessels of the rat. Nature. 1988;335:164-167.
44. Dunn WR, Hardy TA, Brock JA. Electrophysiological effects of activating the peptidergic primary afferent innervation of rat mesenteric arteries. Br J Pharmacol. 2003;140:231-238.
45. Zygmunt PM, Hogestatt ED, Waldeck K, et al. Studies on the effects of anandamide in rat hepatic artery. Br J Pharmacol. 1997;122:1679-1686.